Long intergenic non-protein coding RNA 958 (LINC00958) is highly expressed in various malignancies and is considered a novel target for tumor therapy due to its role in enhancing resistance to radiotherapy and chemotherapy in tumor cells [8]. The gene discussed is PROS1; the disease is neoplasm.